| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Shanghai MicroPort Endovascular MedTech Group Co Ltd
Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016
Shanghai MicroPort Endovascular MedTech Group Co Ltd
Operating Income
Shanghai MicroPort Endovascular MedTech Group Co Ltd
Operating Income Peer Comparison
1066
603658
300888
300832
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016
|
Operating Income
¥556.1m
|
CAGR 3-Years
35%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Operating Income
¥2.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Operating Income
¥912.3m
|
CAGR 3-Years
9%
|
CAGR 5-Years
17%
|
CAGR 10-Years
18%
|
|
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Operating Income
¥1.3B
|
CAGR 3-Years
15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Winner Medical Co Ltd
SZSE:300888
|
Operating Income
¥749.4m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Operating Income
¥1.8B
|
CAGR 3-Years
20%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
See Also
What is Shanghai MicroPort Endovascular MedTech Group Co Ltd's Operating Income?
Operating Income
556.1m
CNY
Based on the financial report for Dec 31, 2023, Shanghai MicroPort Endovascular MedTech Group Co Ltd's Operating Income amounts to 556.1m CNY.
What is Shanghai MicroPort Endovascular MedTech Group Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
40%
Over the last year, the Operating Income growth was 39%. The average annual Operating Income growth rates for Shanghai MicroPort Endovascular MedTech Group Co Ltd have been 35% over the past three years , 40% over the past five years .
You don't have any saved screeners yet
